Record Information
Version1.0
Creation Date2009-06-18 17:03:35 UTC
Update Date2026-05-14 19:35:06 UTC
Accession NumberCHEM000893
Identification
Common NameDeltamethrin
ClassSmall Molecule
DescriptionDeltamethrin is a pyrethroid (type 2) ester insecticide. This material is a member of one of the safest classes of pesticides: synthetic pyrethroids. While mammalian exposure to deltamethrin is classified as safe, this pesticide is highly toxic to aquatic life, particularly fish, and therefore must be used with extreme caution around water. A pyrethroid is a synthetic chemical compound similar to the natural chemical pyrethrins produced by the flowers of pyrethrums (Chrysanthemum cinerariaefolium and C. coccineum). Pyrethroids are common in commercial products such as household insecticides and insect repellents. In the concentrations used in such products, they are generally harmless to human beings but can harm sensitive individuals. They are usually broken apart by sunlight and the atmosphere in one or two days, and do not significantly affect groundwater quality except for being toxic to fish. Since deltamethrin is a neurotoxin, it temporarily attacks (in medical terms, insults) the nervous system of any animal with which it comes into contact. Skin contact can lead to tingling or reddening of the skin local to the application. If taken in through the eyes or mouth, a common symptom is facial paraesthesia, which can feel like many different abnormal sensations, including burning, partial numbness, pins and needles, skin crawling, etc.
Contaminant Sources
  • IARC Carcinogens Group 3
  • My Exposome Chemicals
  • STOFF IDENT Compounds
  • T3DB toxins
  • ToxCast & Tox21 Chemicals
Contaminant Type
  • Bromide Compound
  • Ester
  • Ether
  • Household Toxin
  • Human Neurotoxin
  • Insecticide
  • Metabolite
  • Nitrile
  • Organic Compound
  • Organobromide
  • Pesticide
  • Pyrethroid
  • Synthetic Compound
Chemical Structure
Thumb
Synonyms
ValueSource
(S)-alpha-Cyano-3-phenoxybenzyl (1R)-cis-3-(2,2-dibromovinyl)-2,2-dimethylcyclopropanecarboxylateChEBI
(S)-alpha-Cyano-3-phenoxybenzyl (1R,3R)-3-(2,2-dibromovinyl)-2,2-dimethylcyclopropanecarboxylateChEBI
(S)-Cyano(3-phenoxyphenyl)methyl (1R,3R)-3-(2,2-dibromoethenyl)-2,2-dimethylcyclopropane-1-carboxylateChEBI
BallisticChEBI
Cropro D-sectChEBI
DecamethrinChEBI
DecamethrineChEBI
DecisChEBI
Decis optionsChEBI
DeltaGardChEBI
DeltashieldChEBI
ScaliborChEBI
(S)-a-Cyano-3-phenoxybenzyl (1R)-cis-3-(2,2-dibromovinyl)-2,2-dimethylcyclopropanecarboxylateGenerator
(S)-a-Cyano-3-phenoxybenzyl (1R)-cis-3-(2,2-dibromovinyl)-2,2-dimethylcyclopropanecarboxylic acidGenerator
(S)-alpha-Cyano-3-phenoxybenzyl (1R)-cis-3-(2,2-dibromovinyl)-2,2-dimethylcyclopropanecarboxylic acidGenerator
(S)-Α-cyano-3-phenoxybenzyl (1R)-cis-3-(2,2-dibromovinyl)-2,2-dimethylcyclopropanecarboxylateGenerator
(S)-Α-cyano-3-phenoxybenzyl (1R)-cis-3-(2,2-dibromovinyl)-2,2-dimethylcyclopropanecarboxylic acidGenerator
(S)-a-Cyano-3-phenoxybenzyl (1R,3R)-3-(2,2-dibromovinyl)-2,2-dimethylcyclopropanecarboxylateGenerator
(S)-a-Cyano-3-phenoxybenzyl (1R,3R)-3-(2,2-dibromovinyl)-2,2-dimethylcyclopropanecarboxylic acidGenerator
(S)-alpha-Cyano-3-phenoxybenzyl (1R,3R)-3-(2,2-dibromovinyl)-2,2-dimethylcyclopropanecarboxylic acidGenerator
(S)-Α-cyano-3-phenoxybenzyl (1R,3R)-3-(2,2-dibromovinyl)-2,2-dimethylcyclopropanecarboxylateGenerator
(S)-Α-cyano-3-phenoxybenzyl (1R,3R)-3-(2,2-dibromovinyl)-2,2-dimethylcyclopropanecarboxylic acidGenerator
(S)-Cyano(3-phenoxyphenyl)methyl (1R,3R)-3-(2,2-dibromoethenyl)-2,2-dimethylcyclopropane-1-carboxylic acidGenerator
(S)-Cyano(3-phenoxyphenyl)methyl (1R,3R)-3-(2,2-dibromoethenyl)-2,2-dimethylcyclopropanecarboxylateHMDB
ButoxHMDB
CislinHMDB
CrackdownHMDB
Decis 0.5ulvHMDB
Decis 1.5ulvHMDB
Decis 2.5ulvHMDB
DekametrinHMDB
DeltagranHMDB
DeltamethrineHMDB
EsbecythrinHMDB
Glossinex 200HMDB
K-ObiolHMDB
K-OthrinHMDB
K-OthrineHMDB
New musigieHMDB
Phagase 1HMDB
SuspendHMDB
ZorcisHMDB
Decamethrin, (1S-(1alpha(s*),3alpha))-isomerHMDB
alpha-Cyano-3-phenoxybenzyl (1R,3R)-cis-3-(2,2-dibromovinyl)-2,2-dimethylcyclopropanecarboxylateHMDB
Decamethrin, (1R-(1alpha(r*),3beta))-isomerHMDB
DifexonHMDB
Decamethrin, (1R-(1alpha(r*),3alpha))-isomerHMDB
Decamethrin, (1R-(1alpha(s*),3beta))-isomerHMDB
Decamethrin, (1S-(1alpha(r*),3alpha))-isomerHMDB
NRDC 161HMDB
Chemical FormulaC22H19Br2NO3
Average Molecular Mass505.199 g/mol
Monoisotopic Mass502.973 g/mol
CAS Registry Number52918-63-5
IUPAC Name(S)-cyano(3-phenoxyphenyl)methyl (1R,3R)-3-(2,2-dibromoethenyl)-2,2-dimethylcyclopropane-1-carboxylate
Traditional Namestricker
SMILES[H][C@@](OC(=O)[C@]1([H])[C@]([H])(C=C(Br)Br)C1(C)C)(C#N)C1=CC(OC2=CC=CC=C2)=CC=C1
InChI IdentifierInChI=1S/C22H19Br2NO3/c1-22(2)17(12-19(23)24)20(22)21(26)28-18(13-25)14-7-6-10-16(11-14)27-15-8-4-3-5-9-15/h3-12,17-18,20H,1-2H3/t17-,18+,20-/m0/s1
InChI KeyOWZREIFADZCYQD-NSHGMRRFSA-N
Chemical Taxonomy
Description belongs to the class of organic compounds known as pyrethroids. These are organic compounds similar to the pyrethrins. Some pyrethroids containing a chrysanthemic acid esterified with a cyclopentenone (pyrethrins), or with a phenoxybenzyl group.
KingdomOrganic compounds
Super ClassLipids and lipid-like molecules
ClassFatty Acyls
Sub ClassFatty acid esters
Direct ParentPyrethroids
Alternative Parents
Substituents
  • Pyrethroid skeleton
  • Diphenylether
  • Diaryl ether
  • Benzyloxycarbonyl
  • Phenoxy compound
  • Phenol ether
  • Monocyclic benzene moiety
  • Cyclopropanecarboxylic acid or derivatives
  • Benzenoid
  • Carboxylic acid ester
  • Ketene acetal or derivatives
  • Carboxylic acid derivative
  • Ether
  • Bromoalkene
  • Monocarboxylic acid or derivatives
  • Carbonitrile
  • Nitrile
  • Haloalkene
  • Vinyl halide
  • Vinyl bromide
  • Carbonyl group
  • Organic oxygen compound
  • Organopnictogen compound
  • Organohalogen compound
  • Organobromide
  • Organonitrogen compound
  • Organooxygen compound
  • Organic oxide
  • Hydrocarbon derivative
  • Organic nitrogen compound
  • Aromatic homomonocyclic compound
Molecular FrameworkAromatic homomonocyclic compounds
External Descriptors
Biological Properties
StatusDetected and Not Quantified
OriginExogenous
Cellular Locations
  • Membrane
Biofluid LocationsNot Available
Tissue LocationsNot Available
PathwaysNot Available
Applications
Biological Roles
Chemical Roles
Physical Properties
StateSolid
AppearanceColourless crystalline powder (12).
Experimental Properties
PropertyValue
Melting Point100°C
Boiling PointNot Available
Solubility2e-06 mg/mL at 25°C
Predicted Properties
PropertyValueSource
Water Solubility0.0012 g/LALOGPS
logP6.13ALOGPS
logP5.74ChemAxon
logS-5.6ALOGPS
pKa (Strongest Acidic)10.62ChemAxon
pKa (Strongest Basic)-3.7ChemAxon
Physiological Charge0ChemAxon
Hydrogen Acceptor Count2ChemAxon
Hydrogen Donor Count0ChemAxon
Polar Surface Area59.32 ŲChemAxon
Rotatable Bond Count7ChemAxon
Refractivity124.29 m³·mol⁻¹ChemAxon
Polarizability42.76 ųChemAxon
Number of Rings3ChemAxon
Bioavailability0ChemAxon
Rule of FiveNoChemAxon
Ghose FilterNoChemAxon
Veber's RuleNoChemAxon
MDDR-like RuleYesChemAxon
Spectra
Spectra
Spectrum TypeDescriptionSplash KeyView
Predicted GC-MSPredicted GC-MS Spectrum - GC-MS (Non-derivatized) - 70eV, Positivesplash10-0zfr-3290000000-fc2670ebdafd72059d49Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - 10V, Positivesplash10-0udi-0060190000-d06e22076d1773eb0a44Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - 20V, Positivesplash10-0fb9-0190220000-42d1b03d814ec594ac38Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - 40V, Positivesplash10-004s-2390000000-81cbf54d9ff1579aaee8Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - 10V, Negativesplash10-0udi-0010190000-74170f71f0cac166e6c6Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - 20V, Negativesplash10-0uk9-3151590000-565197ea502710a2b39eSpectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - 40V, Negativesplash10-0006-9430000000-f63f1a3abdb315fa7b1aSpectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - 10V, Positivesplash10-0zfr-0050290000-ae219751f7022f5de5c3Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - 20V, Positivesplash10-0zi1-3291140000-49559be6170bc80632d4Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - 40V, Positivesplash10-0a59-2980000000-38996b5e6c79b7a6a39aSpectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - 10V, Negativesplash10-0udi-0050290000-dabcbd6a2915829d16b4Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - 20V, Negativesplash10-0udj-3290150000-1ee946d210b195df7f8cSpectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - 40V, Negativesplash10-0006-9010100000-1b3ae98f2c93d34b79a9Spectrum
MSMass Spectrum (Electron Ionization)splash10-0ff3-7940000000-0aa3b4a622f8410e5b43Spectrum
1D NMR1H NMR SpectrumNot AvailableSpectrum
1D NMR13C NMR SpectrumNot AvailableSpectrum
Toxicity Profile
Route of ExposureInhalation (9) ; oral (9) ; dermal (9) ; eye contact (9).
Mechanism of ToxicityBoth type I and type II pyrethroids exert their effect by prolonging the open phase of the sodium channel gates when a nerve cell is excited. They appear to bind to the membrane lipid phase in the immediate vicinity of the sodium channel, thus modifying the channel kinetics. This blocks the closing of the sodium gates in the nerves, and thus prolongs the return of the membrane potential to its resting state. The repetitive (sensory, motor) neuronal discharge and a prolonged negative afterpotential produces effects quite similar to those produced by DDT, leading to hyperactivity of the nervous system which can result in paralysis and/or death. Other mechanisms of action of pyrethroids include antagonism of gamma-aminobutyric acid (GABA)-mediated inhibition, modulation of nicotinic cholinergic transmission, enhancement of noradrenaline release, and actions on calcium ions. They also inhibit calium channels and Ca2+, Mg2+-ATPase. (13, 14, 9)
MetabolismDeltamethrin is readily absorbed by the oral route, but less so dermally; absorbed deltamethrin is readily metabolized and excreted. The major degradation pathway of cypermethrin is hydrolysis of the ester linkage to (yield ultimately) 3-phenoxybenzoic acid and 3-(2,2-dichlorovinyl)-2,2- dimethylcyclopropanecarboxylic acid. (From the cis-isomer both cis- and trans- cyclopropanecarboxylic acids are found.) A minor degradative route is ring hydroxylation to give an alpha-cyano-3-(4-hydroxyphenyl)benzyl ester followed by hydrolysis to produce the corresponding hydroxycarboxylic acid (3).
Toxicity ValuesLD50: 4123 mg/kg (Oral, Rat) (4) LD50: >2460 mg/kg (Dermal, Rabbit) (4)
Lethal DoseNot Available
Carcinogenicity (IARC Classification)3, not classifiable as to its carcinogenicity to humans. (5)
Uses/SourcesPyrethroids are used as insecticides. (9)
Minimum Risk LevelNot Available
Health EffectsAt high doses, signs of poisoning attributable to deltamethrin include profuse salivation and pulmonary edema, clonic seizures, opisthotonos (i.e., the spine is bent forward such that a supine body rests on its head and heels), coma, and death. At lower doses, commonly observed effects include paresthesia and erythema (10).
SymptomsFollowing dermal exposure to deltamethrin, feelings of numbness, itching, burning, stinging, tingling, or warmth may occur, that could last for a few hours. Ddizziness, headache, nausea, muscle twitching, reduced energy, and changes in awareness can reult from inhalation or ingestion of large amounts of deltamethrin. Paralysis can occur after exposure (9).
TreatmentFollowing oral exposure, the treatment is symptomatic and supportive and includes monitoring for the development of hypersensitivity reactions with respiratory distress. Provide adequate airway management when needed. Gastric decontamination is usually not required unless the pyrethrin product is combined with a hydrocarbon. Following inhalation exposure, move patient to fresh air. monitor for respiratory distress. If cough or difficulty breathing develops, evaluate for respiratory tract irritation, bronchitis, or pneumonitis. Administer oxygen and assist ventilation as required. Treat bronchospasm with inhaled beta2 agonist and oral or parenteral corticosteroids. In case of eye exposure, irrigate exposed eyes with copious amounts of room temperature water for at least 15 minutes. If irritation, pain, swelling, lacrimation, or photophobia persist, the patient should be seen in a health care facility. If the contamination occurs through dermal exposure, Remove contaminated clothing and wash exposed area thoroughly with soap and water. A physician may need to examine the area if irritation or pain persists. Vitamin E topical application is highly effective in relieving parenthesis. (6)
Concentrations
Not Available
DrugBank IDDB13600
HMDB IDHMDB0041866
FooDB IDNot Available
Phenol Explorer IDNot Available
KNApSAcK IDNot Available
BiGG IDNot Available
BioCyc IDNot Available
METLIN IDNot Available
PDB IDNot Available
Wikipedia LinkDeltamethrin
Chemspider ID37079
ChEBI ID4388
PubChem Compound ID40585
Kegg Compound IDC10985
YMDB IDNot Available
ECMDB IDNot Available
References
Synthesis ReferenceNot Available
MSDSNot Available
General References
1. https://www.ncbi.nlm.nih.gov/pubmed/?term=12049274
2. https://www.ncbi.nlm.nih.gov/pubmed/?term=12706396
3. https://www.ncbi.nlm.nih.gov/pubmed/?term=14563173
4. https://www.ncbi.nlm.nih.gov/pubmed/?term=15088704
5. https://www.ncbi.nlm.nih.gov/pubmed/?term=16169030
6. https://www.ncbi.nlm.nih.gov/pubmed/?term=16310970
7. https://www.ncbi.nlm.nih.gov/pubmed/?term=17507155
8. https://www.ncbi.nlm.nih.gov/pubmed/?term=20839770
9. https://www.ncbi.nlm.nih.gov/pubmed/?term=21324359
10. https://www.ncbi.nlm.nih.gov/pubmed/?term=21771693
11. https://www.ncbi.nlm.nih.gov/pubmed/?term=32249328
12. https://www.ncbi.nlm.nih.gov/pubmed/?term=32485514
13. https://www.ncbi.nlm.nih.gov/pubmed/?term=32596996
14. https://www.ncbi.nlm.nih.gov/pubmed/?term=32651933
15. https://www.ncbi.nlm.nih.gov/pubmed/?term=32757256
16. https://www.ncbi.nlm.nih.gov/pubmed/?term=32799158
17. https://www.ncbi.nlm.nih.gov/pubmed/?term=32876326
18. https://www.ncbi.nlm.nih.gov/pubmed/?term=32914306
19. https://www.ncbi.nlm.nih.gov/pubmed/?term=32976580
20. https://www.ncbi.nlm.nih.gov/pubmed/?term=33001569
21. https://www.ncbi.nlm.nih.gov/pubmed/?term=33035892
22. https://www.ncbi.nlm.nih.gov/pubmed/?term=33046642
23. https://www.ncbi.nlm.nih.gov/pubmed/?term=33069802
24. Simons K, Toomre D: Lipid rafts and signal transduction. Nat Rev Mol Cell Biol. 2000 Oct;1(1):31-9.
25. Watson AD: Thematic review series: systems biology approaches to metabolic and cardiovascular disorders. Lipidomics: a global approach to lipid analysis in biological systems. J Lipid Res. 2006 Oct;47(10):2101-11. Epub 2006 Aug 10.
26. Sethi JK, Vidal-Puig AJ: Thematic review series: adipocyte biology. Adipose tissue function and plasticity orchestrate nutritional adaptation. J Lipid Res. 2007 Jun;48(6):1253-62. Epub 2007 Mar 20.
27. Lingwood D, Simons K: Lipid rafts as a membrane-organizing principle. Science. 2010 Jan 1;327(5961):46-50. doi: 10.1126/science.1174621.
28. The lipid handbook with CD-ROM